| Real-time alerting system for COVID-19 and other stress events using wearable data A Alavi, GK Bogu, M Wang, ES Rangan, AW Brooks, Q Wang, E Higgs, ... Nature medicine 28 (1), 175-184, 2022 | 114 | 2022 |
| Probiotic Lactobacillus reuteri Ameliorates Disease Due to Enterohemorrhagic Escherichia coli in Germfree Mice KA Eaton, A Honkala, TA Auchtung, RA Britton Infection and immunity 79 (1), 185-191, 2011 | 105 | 2011 |
| Guanylate-binding protein 1: an emerging target in inflammation and cancer AT Honkala, D Tailor, SV Malhotra Frontiers in immunology 10, 3139, 2020 | 90 | 2020 |
| Harnessing the predictive power of preclinical models for oncology drug development A Honkala, SV Malhotra, S Kummar, MR Junttila Nature reviews Drug discovery 21 (2), 99-114, 2022 | 63 | 2022 |
| Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer D Tailor, A Resendez, FJ Garcia-Marques, M Pandrala, CC Going, ... Cell Chemical Biology 28 (8), 1206-1220. e6, 2021 | 37 | 2021 |
| Optical microscopy and coherence tomography of cancer in living subjects P Si, A Honkala, A de la Zerda, BR Smith Trends in Cancer 6 (3), 205-222, 2020 | 26 | 2020 |
| Longitudinal profiling of the microbiome at four body sites reveals core stability and individualized dynamics during health and disease X Zhou, X Shen, JS Johnson, DJ Spakowicz, M Agnello, W Zhou, M Avina, ... Cell Host & Microbe 32 (4), 506-526. e9, 2024 | 22 | 2024 |
| Cancer immunotherapy getting brainy: visualizing the distinctive CNS metastatic niche to illuminate therapeutic resistance M Owyong, N Hosseini-Nassab, G Efe, A Honkala, RJE van den Bijgaart, ... Drug Resistance Updates 33, 23-35, 2017 | 20 | 2017 |
| Real-time alerting system for COVID-19 using wearable data A Alavi, GK Bogu, M Wang, ES Rangan, AW Brooks, Q Wang, E Higgs, ... medRxiv, 2021 | 11 | 2021 |
| Early detection of SARS‐CoV‐2 and other infections in solid organ transplant recipients and household members using wearable devices BJ Keating, EH Mukhtar, ED Elftmann, FR Eweje, H Gao, LI Ibrahim, ... Transplant International 34 (6), 1019-1031, 2021 | 11 | 2021 |
| Nanoparticles decorated with granulocyte-colony stimulating factor for targeting myeloid cells K Margulis, A Honkala, I Kalashnikova, SE Noll, M Hill, RN Zare, BR Smith Nanoscale 12 (4), 2752-2763, 2020 | 6 | 2020 |
| Long-read sequencing of SARS-CoV-2 reveals novel transcripts and a diverse complex transcriptome landscape J Li-Pook-Than, S Banuelos, A Honkala, MK Sahoo, BA Pinsky, ... bioRxiv, 2021.03. 05.434150, 2021 | 2 | 2021 |
| Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy A Dheeraj, FJG Marques, D Tailor, A Bermudez, A Resendez, M Pandrala, ... Cell Reports Medicine 5 (5), 2024 | | 2024 |
| Myeloid cell-targeted nanoparticles and related compositions and methods A Honkala, B Smith, K Margulis, R Zare US Patent App. 17/783,939, 2022 | | 2022 |
| Monitoring Health Through Wearables and Connected Devices A HONKALA, M SNYDER Journal of The Society of Instrument and Control Engineers 61 (8), 572-577, 2022 | | 2022 |
| Targeting mRNA processing pathways in ovarian cancer with a small molecule inhibitor D Tailor, CF Tsai, A Honkala, W Li, T Liu, T Pejovic, SV Malhotra Cancer Research 82 (12_Supplement), 2645-2645, 2022 | | 2022 |
| Lactobacillus Reuteri Ameliorates Disease Due to Enterohemorrhagic E. coli in Germ Free Mice KA Eaton, A Honkala, T Auchtung, R Britton Gastroenterology 138 (5), S52-S52, 2010 | | 2010 |
| Mycobacterium w-a promising immunotherapeutic intervention for diseases K Stefan, R Gordon, A Rolig, A Honkala, D Tailor, LE Davis, RI Modi, ... Frontiers in Immunology 15, 1450118, 0 | | |
Dhanir TailorOregon Health and Science University, OR, USA在 ohsu.edu 的电子邮件经过验证
